Also known as: Daewoong Pharmaceutical
Daewoong Pharmaceutical is a leading R&D-oriented pharmaceutical company that develops and manufactures medicines and supplies products through a global healthcare platform. The company emphasizes formulation, manufacturing, and commercial supply across its drug portfolio.
South Korean pharmaceutical companies are expanding digital healthcare businesses as they seek new revenue sources. The domestic market recorded 7.7409 trillion won in sales in 2024, while companies including Daewoong Pharmaceutical, Dong-A ST, Handok and Yuhan are advancing products and investments.
Global pharmaceutical R&D deal values surged 49% to $86.7 billion in 2025 as companies concentrate investments in AI-powered drug discovery platforms, with average deal sizes reaching a record $1.16 billion despite fewer total partnerships.
